Meridian Bioscience Stock

Meridian Bioscience Dividend

Dividend of Meridian Bioscience (VIVO) as of Aug 4, 2026.

Dividend

0.00USD

Dividend yield

3.50 %

Last updated:

How much dividend does Meridian Bioscience 2026 pay?

According to the latest status from August 2026, Meridian Bioscience paid a total of 0.00 USD per share in dividends within the last 12 months. With the current Meridian Bioscience price of 3.57 USD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

At today's price the dividend yield works out to roughly 3.50%. The payout ratio is around 22% of earnings.

Historical Meridian Bioscience Dividends

PaydateDividend
3/1/20190.13USD
12/16/20180.13USD
9/9/20180.13USD
6/4/20180.13USD
3/2/20180.13USD
12/17/20170.13USD
9/3/20170.13USD
6/4/20170.13USD
3/2/20170.13USD
12/17/20160.20USD
9/4/20160.20USD
6/5/20160.20USD
3/4/20160.20USD
12/12/20150.20USD
8/30/20150.20USD
5/30/20150.20USD
3/1/20150.20USD
12/13/20140.20USD
8/31/20140.20USD
6/1/20140.20USD

Is the Meridian Bioscience Dividend Safe?

Meridian Bioscience has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Meridian Bioscience dividend payout ratio

In 2025, Meridian Bioscience had a payout ratio of 56.51%. The payout ratio indicates the percentage of the company's profits that Meridian Bioscience distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
90.91 %
Jan 1, 2019
21.93 %
Jan 1, 2020
70.29 %
Jan 1, 2021
61.04 %
Jan 1, 2022
51.09 %
Jan 1, 2023 (e)
60.81 %
Jan 1, 2024 (e)
57.65 %
Jan 1, 2025 (e)
56.51 %

Dividend Details

Understanding Meridian Bioscience's Dividend Distributions

Meridian Bioscience’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Meridian Bioscience's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Meridian Bioscience's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Meridian Bioscience’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meridian Bioscience stock

The current dividend yield of Meridian Bioscience is 3.50 %.

Meridian Bioscience pays a dividend, distributed in the months of , , , .

Meridian Bioscience paid dividends every year for the past 0 years.

Meridian Bioscience is assigned to the 'Health' sector.

To receive the latest dividend of Meridian Bioscience from amounting to 0.13 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Meridian Bioscience are distributed in USD.

Dividend calendar 2026
Access this data via the Eulerpool API
Get Free API Key

All Key Metrics — Meridian Bioscience